NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update

Go back to NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: NRXP) Delayed: 3.90 --0 (-0%)
Previous Close $3.90    52 Week High
Open $3.90    52 Week Low
Day High $3.90    P/E N/A 
Day Low $3.90    EPS
Volume 4,317